Shots: Novartis sells a part of Sandoz US, which includes ~300 products that generated $0.6B in H1’18 This transaction includes development projects along with ~300 products to Aurobindo Pharma USA Inc. for $0.9B in cash & $0.1B of potential earn-outs, with expected closure in 2019 Aurobindo will also take over manufacturing facilities in Wilson, North […]Read More
